Company Filing History:
1 out of 832,891 Years Active: 1988
Title: The Innovative Contributions of Michael T DiMuzio in Protein Research
Introduction: Michael T DiMuzio, an inventive mind based in Chicago, IL, has made significant strides in the field of protein research. With a focus on the development of biologically relevant proteins, his work provides insights that are likely to advance therapeutic options in medicine.
Latest Patents: DiMuzio is the inventor of a patented protein known as the Cartilage-derived leukocyte elastase-inhibitor. This innovative protein, or a pharmaceutically acceptable salt thereof, possesses a molecular weight ranging from 10,000-30,000 Daltons. Notable characteristics of this invention include an isoelectric point greater than 9.5 and a specific N-terminal sequence that plays a critical role in its biological activity. Furthermore, the patent details methods for the isolation and purification of this protein, along with its compositions and potential applications in medical treatments.
Career Highlights: With a singular patent to his name, Michael T DiMuzio’s contributions reflect a deep commitment to research and innovation in the biology of proteins. His work exemplifies how a focused approach to invention can lead to significant advancements in clinical applications.
Collaborations: DiMuzio has collaborated with esteemed professionals such as Klaus E Kuettner and Dominique Tripier. These partnerships highlight the importance of teamwork in driving innovative research and developing new solutions in the scientific community.
Conclusion: Michael T DiMuzio remains a pivotal figure in protein research, particularly in the study of mechanisms that inhibit leukocyte elastase. His work continues to inspire progress in therapeutic research, illustrating the remarkable impact that dedicated inventors can have on science and medicine.